Multiple Sclerosis

Add-on corticosteroids beneficial in MS

28/06/2010 | A combination regimen with monthly high-dose oral methylprednisolone further reduces the risk of relapses in treatment-naive patients with relapsing remitting multiple sclerosis who have recently started to receive interferon beta-1a therapy, research shows.


Effect of latitude on MS incidence challenged

03/05/2010 | The concept that multiple sclerosis is more common among people living at high latitudes may not be valid, except in Australia and New Zealand, a recent review has concluded.


MS risks higher for summer babies

03/05/2010 | Vitamin D supplementation during pregnancy needs to be evaluated to help prevent multiple sclerosis, Melbourne researchers say this week.


Vitamin D has 'protective' effect on MS

06/04/2010 | Mounting evidence suggests vitamin D has a protective effect in multiple sclerosis, an expert says, however patients should be warned against taking mega doses of supplements.


Add-on daclizumab reduces MS disease activity

20/02/2010 | Add-on daclizumab treatment might reduce multiple sclerosis disease activity more than standard interferon beta treatment alone, research suggests.


Oral MS drugs offer new horizon

25/01/2010 | Two new oral drugs shown this week to lower relapse rates in patients with multiple sclerosis provide a 'new horizon' for patients and a welcome increase in the range of treatment options, says William Carroll, a neurologist from Sir Charles Gairdner Hospital, Perth.


Early treatment halves risk of MS progression

12/10/2009 | Early treatment with glatiramer acetate can almost halve the risk of patients progressing from clinically isolated syndrome to clinically definite MS, a study finds.


Smoking sparks MS progression

16/07/2009 | Cigarette smoking has an adverse influence on the progression of MS and accelerates conversion from a relapsing-remitting to a progressive course, a recent study has found.


Adding oral steroids to interferon beta-1a reduces relapse in MS

11/05/2009 | Two new studies suggest that the addition of oral methylprednisolone to subcutaneous interferon beta-1a substantially reduces the relapse rate in patients with relapsing-remitting multiple sclerosis.


Stem cells show promise for relapsing-remitting MS

05/02/2009 | Autologous non-myeloablative haemopoietic stem cell transplantation may prevent neurological progression and improve neurological disability in patients with relapsing-remitting MS, results of a phase II study show.


More Multiple Sclerosis news